TASS informs about this with reference to the associate professor of the Department of Biochemistry of the Kazan Federal University, virologist Vladimir Oberemka.
“We will move from preclinical trials to clinical trials first on a group of volunteers, which first of all will show the safety of the vaccine for humans,” he said.
According to him, after that the dose and combination of constructs will be selected so that "the largest possible number of people form antibodies."
“In the spring we will definitely try to do it,” the scientist said.
In October 2020, it became known that scientists from the Vernadsky Federal University have developed a new vaccine against coronavirus. Oberemok said that one of the features of the drug is that it can be taken intranasally, without injections.